What to expect from JAK inhibitor therapy for alopecia areata

Alopecia areata can cause smooth, sharply defined patches of hair loss when immune signals affect follicles. A JAK inhibitor works inside immune signalling pathways. The aim is to quiet signals associated with active hair loss and create conditions in which follicles can resume producing hair. New growth may be uneven, fine, or lighter at first, and treatment response differs between people. Hair can shed again if treatment is stopped, so your dermatologist will discuss how response and maintenance should be assessed.

Your clinician will review your medical history, medicines, infections, vaccination status, and any factors that affect immune treatment. Follow the prescribed schedule and do not change the dose without advice. Attend blood tests or other checks requested by your care team. Keep a simple record of scalp patches, eyebrow or eyelash changes, and new symptoms so progress is easier to discuss. Gentle hair care can reduce breakage while regrowth is developing.

Seek prompt medical advice for fever, a persistent cough, painful skin lesions, unusual tiredness, unexplained bruising, or signs of an infection while taking the medicine. Urgent help is needed for severe breathing difficulty, chest pain, sudden weakness, or swelling of the face or throat. These symptoms may have causes unrelated to alopecia areata, but they should not be ignored during immune-modifying treatment.

Ask which JAK inhibitor is appropriate for you, what improvement would count as a useful response, which checks are needed before and during treatment, and what to do after a missed dose. Discuss pregnancy plans, vaccinations, travel, infection exposure, and whether you need advice about eyebrow, eyelash, or scalp protection.